GlaxoSmithKline, Britain’s biggest pharmaceuticals company, is moving ahead with plans to build its first new UK factory for 30 years. The maker of Panadol and Lucozade wants to expand in the UK following tax breaks on innovation introduced by Chancellor George Osborne. Around 15,000 of its 96,000 employees are based in Britain. The company hopes to create 1,000 more jobs at its new plant, which will also result in more taxes flowing in to the UK Exchequer. Andrew Witty, the chief executive, said: ‘Because of changes in the UK tax regime, it will be our intention to bring more activity to Britain and take advantage of the situation here and increase our contribution to Britain.
